A Randomized Phase 2 Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/metastatic Colorectal Cancer (mcrc) with HER2 Amplification: SWOG S1613.Kanwal Pratap Singh Raghav,Katherine A. Guthrie,Scott Kopetz,Benjamin R. Tan,Crystal S. Denlinger,Marwan Fakih,Michael J. Overman,Arvind Dasari,Larry R. Corum, Lee G. Hicks, Mital Patel,Benjamin T. Esparaz,Syed Mohammad Ali Kazmi,Nitya Alluri,Sarah Colby,Sepideh Gholami,Philip Jordan Gold,E. Gabriela Chiorean,Howard S. Hochster, Philip Agop PhilipJournal of Clinical Oncology（2023）引用 5|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
